{
    "hands_on_practices": [
        {
            "introduction": "Effective nutritional support requires not only providing substrates but also monitoring the patient's metabolic response. Nitrogen balance serves as a crucial quantitative tool to assess the net effect of protein synthesis and breakdown, reflecting whether the patient is in an anabolic (building tissue), catabolic (losing tissue), or neutral state. This practice will guide you through the fundamental calculation of nitrogen balance, a skill essential for titrating protein delivery to meet the metabolic demands of a surgical patient and promote optimal recovery .",
            "id": "5116542",
            "problem": "A postoperative patient in the surgical intensive care unit is receiving parenteral amino acid solution providing a daily protein intake of $120\\,\\text{g/day}$. A 24-hour urine collection shows urinary urea nitrogen (UUN) of $18\\,\\text{g/day}$. For a patient with moderate physiological stress following major abdominal surgery, assume non-urinary nitrogen losses of $4\\,\\text{g/day}$. Use mass conservation of nitrogen: nitrogen balance equals nitrogen intake minus total nitrogen losses. Use the widely accepted compositional fact that dietary protein contains approximately $16\\%$ nitrogen by mass. Compute the patient's nitrogen balance and determine the additional protein intake required to achieve a target nitrogen balance of $+2\\,\\text{g/day}$. Round both quantities to three significant figures and express both answers in $\\text{g/day}$.",
            "solution": "The problem is first validated against the required criteria.\n\n### Problem Validation\n**Step 1: Extract Givens**\n-   Daily protein intake: $120\\,\\text{g/day}$.\n-   Urinary urea nitrogen (UUN): $18\\,\\text{g/day}$.\n-   Non-urinary nitrogen losses: $4\\,\\text{g/day}$.\n-   Nitrogen balance formula: Nitrogen balance = Nitrogen intake - Total nitrogen losses.\n-   Compositional fact: Protein contains approximately $16\\%$ nitrogen by mass.\n-   Target nitrogen balance: $+2\\,\\text{g/day}$.\n-   Required calculation: Compute the patient's current nitrogen balance and the additional protein intake required to achieve the target balance.\n-   Rounding instruction: Round both quantities to three significant figures.\n\n**Step 2: Validate Using Extracted Givens**\n-   **Scientifically Grounded:** The problem is based on standard, fundamental principles of clinical nutrition and metabolic monitoring in surgery. The concept of nitrogen balance, the estimation of nitrogen content in protein (the $6.25$ factor, or $16\\%$ nitrogen), and the calculation of total nitrogen loss from urinary and non-urinary components are all standard practices in the field. The values provided are clinically plausible for a patient under moderate metabolic stress.\n-   **Well-Posed:** The problem provides all necessary data and relationships to compute a unique solution. The objectives are clearly stated.\n-   **Objective:** The problem is stated in precise, quantitative, and unbiased language.\n\n**Step 3: Verdict and Action**\nThe problem is scientifically sound, well-posed, and objective. It is therefore deemed **valid**. The solution will now be derived.\n\n### Solution Derivation\nThe solution is determined in two parts: first, calculating the current nitrogen balance, and second, calculating the additional protein intake required to meet the target nitrogen balance.\n\nLet $P_{in}$ be the initial protein intake, $N_{in}$ be the nitrogen intake, $UUN$ be the urinary urea nitrogen, $N_{non-urinary}$ be the non-urinary nitrogen losses, $N_{loss, total}$ be the total nitrogen losses, and $N_{balance}$ be the nitrogen balance. The mass fraction of nitrogen in protein is given as $f_N = 16\\% = 0.16$.\n\nThe given values are:\n-   $P_{in} = 120\\,\\text{g/day}$\n-   $UUN = 18\\,\\text{g/day}$\n-   $N_{non-urinary} = 4\\,\\text{g/day}$\n-   $N_{balance, target} = +2\\,\\text{g/day}$\n\n**Part 1: Calculation of Current Nitrogen Balance**\n\nFirst, convert the protein intake into nitrogen intake using the given mass fraction.\n$$N_{in} = P_{in} \\times f_N$$\n$$N_{in} = 120\\,\\text{g/day} \\times 0.16 = 19.2\\,\\text{g/day}$$\n\nNext, calculate the total nitrogen loss by summing the urinary and non-urinary components. The problem statement implies that the total nitrogen loss is the sum of the measured UUN and the estimated non-urinary losses.\n$$N_{loss, total} = UUN + N_{non-urinary}$$\n$$N_{loss, total} = 18\\,\\text{g/day} + 4\\,\\text{g/day} = 22\\,\\text{g/day}$$\n\nNow, compute the current nitrogen balance using the defined formula.\n$$N_{balance} = N_{in} - N_{loss, total}$$\n$$N_{balance} = 19.2\\,\\text{g/day} - 22\\,\\text{g/day} = -2.8\\,\\text{g/day}$$\n\nRounding to three significant figures, the current nitrogen balance is $-2.80\\,\\text{g/day}$.\n\n**Part 2: Calculation of Additional Protein Intake Required**\n\nThe goal is to achieve a target nitrogen balance, $N_{balance, target} = +2\\,\\text{g/day}$. We assume that the total nitrogen loss, $N_{loss, total}$, which reflects the patient's catabolic state, remains constant at $22\\,\\text{g/day}$.\n\nLet $N_{in, new}$ be the new required nitrogen intake to achieve this target. The nitrogen balance equation becomes:\n$$N_{balance, target} = N_{in, new} - N_{loss, total}$$\n\nWe solve for $N_{in, new}$:\n$$N_{in, new} = N_{balance, target} + N_{loss, total}$$\n$$N_{in, new} = 2\\,\\text{g/day} + 22\\,\\text{g/day} = 24\\,\\text{g/day}$$\n\nThis required nitrogen intake must be converted back to the corresponding total protein intake, denoted as $P_{in, new}$.\n$$P_{in, new} = \\frac{N_{in, new}}{f_N}$$\n$$P_{in, new} = \\frac{24\\,\\text{g/day}}{0.16} = 150\\,\\text{g/day}$$\n\nThe problem asks for the *additional* protein intake required, denoted as $\\Delta P_{in}$. This is the difference between the new required intake and the initial intake.\n$$\\Delta P_{in} = P_{in, new} - P_{in}$$\n$$\\Delta P_{in} = 150\\,\\text{g/day} - 120\\,\\text{g/day} = 30\\,\\text{g/day}$$\n\nRounding to three significant figures, the additional protein intake required is $30.0\\,\\text{g/day}$.\n\nThe two final answers are the current nitrogen balance of $-2.80\\,\\text{g/day}$ and the required additional protein intake of $30.0\\,\\text{g/day}$.",
            "answer": "$$\n\\boxed{\n\\begin{pmatrix} -2.80 & 30.0 \\end{pmatrix}\n}\n$$"
        },
        {
            "introduction": "While providing adequate energy is a primary goal of parenteral nutrition, the rate of carbohydrate administration must be carefully controlled to prevent metabolic complications. The Glucose Infusion Rate (GIR) is a standardized measure that is critical for avoiding hyperglycemia, excess $\\text{CO}_2$ production, and de novo lipogenesis, which can lead to hepatic steatosis. This exercise focuses on the precise calculation of GIR from a given parenteral nutrition prescription, a fundamental safety check to ensure that glucose delivery remains within a safe therapeutic window .",
            "id": "5116567",
            "problem": "A postoperative adult undergoing systemic surgery is maintained on continuous Parenteral Nutrition (PN) via a central line. The PN dextrose concentration is $25\\%$ and is compounded to deliver a total of $300\\,\\mathrm{g/day}$ of dextrose. The patient’s body mass is $80\\,\\mathrm{kg}$, and the infusion is continuous over a $24\\,\\mathrm{h}$ period. Using only the core definition of Glucose Infusion Rate (GIR) as the rate of dextrose delivery per unit body mass per unit time, together with standard unit conversions between grams and milligrams and between days and minutes, derive the GIR in $\\mathrm{mg/kg/min}$. Then, based on a conservative target of $\\leq 4\\,\\mathrm{mg/kg/min}$ to reduce de novo lipogenesis and hepatic steatosis risk, determine whether the calculated GIR exceeds the target. Round your computed GIR to four significant figures and express it in $\\mathrm{mg/kg/min}$.",
            "solution": "The problem statement is subjected to validation.\n\n### Step 1: Extract Givens\n-   Parenteral Nutrition (PN) dextrose concentration: $25\\%$\n-   Total dextrose delivery: $300\\,\\mathrm{g/day}$\n-   Patient's body mass: $80\\,\\mathrm{kg}$\n-   Infusion period: continuous over $24\\,\\mathrm{h}$\n-   Core definition of Glucose Infusion Rate (GIR): rate of dextrose delivery per unit body mass per unit time\n-   Required unit conversions: grams to milligrams, days to minutes\n-   Target GIR: $\\leq 4\\,\\mathrm{mg/kg/min}$\n-   Required precision: Round computed GIR to four significant figures.\n\n### Step 2: Validate Using Extracted Givens\nThe problem is assessed for validity.\n-   **Scientifically Grounded**: The problem is firmly based on established principles of clinical nutrition and parenteral feeding. The concept of Glucose Infusion Rate (GIR), the provided values for dextrose mass, patient weight, and the target GIR are standard in medical practice. The clinical rationale (reducing risk of de novo lipogenesis and hepatic steatosis) is a valid and critical consideration in metabolic support.\n-   **Well-Posed**: The problem is well-posed. It provides all necessary data to compute the desired quantity. The question is unambiguous and leads to a unique, stable solution.\n-   **Objective**: The problem is stated in precise, quantitative, and objective language, free of subjective claims.\n-   **Incomplete or Contradictory Setup**: The problem is self-contained. The specification of a $25\\%$ dextrose concentration is supplementary information but not required for the calculation, as the total mass of infused dextrose is given directly ($300\\,\\mathrm{g/day}$). This does not create a contradiction but rather represents a common scenario where multiple related data points are available.\n-   **Unrealistic or Infeasible**: The values provided are clinically realistic for an adult postoperative patient.\n\n### Step 3: Verdict and Action\nThe problem is deemed **valid**. A solution will be provided.\n\nThe Glucose Infusion Rate (GIR) is defined as the mass of glucose (dextrose) infused per unit of patient body mass per unit of time. The objective is to calculate this rate in units of milligrams per kilogram per minute ($\\mathrm{mg/kg/min}$).\n\nLet $M_d$ be the total mass of dextrose infused, $m_p$ be the patient's body mass, and $T$ be the total duration of the infusion.\nThe GIR can be expressed by the formula:\n$$\n\\text{GIR} = \\frac{M_d}{m_p \\cdot T}\n$$\nThe given values are:\n-   $M_d = 300\\,\\mathrm{g}$\n-   $m_p = 80\\,\\mathrm{kg}$\n-   $T = 24\\,\\mathrm{h}$\n\nThe problem specifies that the total delivery is $300\\,\\mathrm{g/day}$ over a $24\\,\\mathrm{h}$ period, so we can set $T = 1\\,\\mathrm{day}$. Substituting the given values into the formula yields:\n$$\n\\text{GIR} = \\frac{300\\,\\mathrm{g}}{80\\,\\mathrm{kg} \\cdot 1\\,\\mathrm{day}}\n$$\nTo express the GIR in the required units of $\\mathrm{mg/kg/min}$, we must apply unit conversion factors.\nThe conversion from grams ($\\mathrm{g}$) to milligrams ($\\mathrm{mg}$) is:\n$$\n1\\,\\mathrm{g} = 1000\\,\\mathrm{mg}\n$$\nThe conversion from days ($\\mathrm{day}$) to minutes ($\\mathrm{min}$) is:\n$$\n1\\,\\mathrm{day} = 24\\,\\mathrm{hours/day} \\times 60\\,\\mathrm{minutes/hour} = 1440\\,\\mathrm{min}\n$$\nWe apply these conversion factors to our expression for GIR. This is formally achieved by multiplying by unity in the form of conversion-factor ratios:\n$$\n\\text{GIR} = \\left( \\frac{300\\,\\mathrm{g}}{80\\,\\mathrm{kg} \\cdot 1\\,\\mathrm{day}} \\right) \\times \\left( \\frac{1000\\,\\mathrm{mg}}{1\\,\\mathrm{g}} \\right) \\times \\left( \\frac{1\\,\\mathrm{day}}{1440\\,\\mathrm{min}} \\right)\n$$\nThe units of grams and days cancel out, leaving the desired units of $\\mathrm{mg/kg/min}$:\n$$\n\\text{GIR} = \\frac{300 \\times 1000}{80 \\times 1440} \\, \\frac{\\mathrm{mg}}{\\mathrm{kg} \\cdot \\mathrm{min}}\n$$\nNow, we perform the arithmetic calculation:\n$$\n\\text{GIR} = \\frac{300000}{115200} \\, \\frac{\\mathrm{mg}}{\\mathrm{kg} \\cdot \\mathrm{min}}\n$$\n$$\n\\text{GIR} \\approx 2.6041666... \\, \\frac{\\mathrm{mg}}{\\mathrm{kg} \\cdot \\mathrm{min}}\n$$\nThe problem requires the result to be rounded to four significant figures. The fifth significant figure is $1$, so we round down.\n$$\n\\text{GIR} \\approx 2.604 \\, \\frac{\\mathrm{mg}}{\\mathrm{kg} \\cdot \\mathrm{min}}\n$$\nThe second part of the problem is to determine whether this calculated GIR exceeds the conservative target of $\\leq 4\\,\\mathrm{mg/kg/min}$.\nLet $\\text{GIR}_{\\text{target}} = 4\\,\\mathrm{mg/kg/min}$. We compare our calculated value to this target:\n$$\n2.604\\,\\mathrm{mg/kg/min} \\leq 4\\,\\mathrm{mg/kg/min}\n$$\nThe inequality is true. Therefore, the calculated Glucose Infusion Rate does not exceed the specified conservative target.\nThe information regarding the $25\\%$ dextrose concentration was not necessary for this calculation, as the total daily mass of dextrose was provided directly.",
            "answer": "$$\n\\boxed{2.604}\n$$"
        },
        {
            "introduction": "This clinical scenario moves from routine calculation to critical intervention, addressing one of the most feared complications of nutritional rehabilitation: refeeding syndrome. The practice challenges you to apply your understanding of the profound metabolic shifts—particularly involving phosphate, potassium, and magnesium—that occur when nutrition is reintroduced in a malnourished patient. By analyzing the patient's data and evaluating management options, you will develop the clinical reasoning needed to promptly identify and correctly manage this life-threatening condition, reinforcing the principle that how you feed is as important as what you feed .",
            "id": "5116549",
            "problem": "A $62$-year-old man with gastric outlet obstruction complicated by prolonged inadequate oral intake is postoperative day $3$ after laparoscopic gastrojejunostomy. His weight is $70\\,\\mathrm{kg}$ (down from $79\\,\\mathrm{kg}$ one month ago), serum albumin is $2.6\\,\\mathrm{g/dL}$, and there is no edema. A polymeric enteral nutrition (EN) formula with energy density $1.5\\,\\mathrm{kcal/mL}$ was initiated at $30\\,\\mathrm{mL/h}$ via a nasojejunal tube $24$ hours ago. Baseline electrolytes before EN: phosphate $3.2\\,\\mathrm{mg/dL}$, potassium $3.6\\,\\mathrm{mEq/L}$, magnesium $1.7\\,\\mathrm{mg/dL}$, creatinine $0.9\\,\\mathrm{mg/dL}$, glucose $102\\,\\mathrm{mg/dL}$. Current labs after $24$ hours of EN: phosphate $1.1\\,\\mathrm{mg/dL}$, potassium $3.2\\,\\mathrm{mEq/L}$, magnesium $1.5\\,\\mathrm{mg/dL}$, creatinine $0.9\\,\\mathrm{mg/dL}$, glucose $188\\,\\mathrm{mg/dL}$ on correction-scale insulin. Vital signs are stable; there is no respiratory distress or chest pain. The surgical team is concerned about refeeding physiology.\n\nUsing fundamental principles of refeeding pathophysiology (insulin-mediated intracellular shifts, adenosine triphosphate [ATP] demand, and electrolyte redistribution) and established clinical safety limits for electrolyte repletion in surgical patients with normal renal function, choose the best immediate management plan that specifies both a reduction in EN delivery and phosphate repletion with explicit dosing and route. Assume the EN formula concentration and patient weight as given; the goal is to minimize risk while correcting the electrolyte derangement.\n\nA. Reduce EN delivery to approximately $10\\,\\mathrm{kcal/kg/day}$ by decreasing the EN rate to about $20\\,\\mathrm{mL/h}$ of the $1.5\\,\\mathrm{kcal/mL}$ formula; administer intravenous (IV) potassium phosphate $30\\,\\mathrm{mmol}$ over $4$–$6$ hours; give IV magnesium sulfate $2\\,\\mathrm{g}$; give thiamine $100\\,\\mathrm{mg}$ IV before further advancing feeds; monitor phosphate, potassium, magnesium, and glucose every $6$–$8$ hours and advance EN by $\\leq 20\\%$ per day as electrolytes stabilize.\n\nB. Maintain EN at $30\\,\\mathrm{mL/h}$; administer oral neutral phosphate $500\\,\\mathrm{mg}$ (approximately $16\\,\\mathrm{mmol}$ phosphorus) twice daily; recheck electrolytes in $24$ hours without additional changes.\n\nC. Stop EN entirely for $72$ hours; administer IV sodium phosphate $60\\,\\mathrm{mmol}$ over $1$ hour; initiate an insulin infusion to target glucose $<110\\,\\mathrm{mg/dL}$; resume EN at goal thereafter.\n\nD. Reduce EN to $50\\%$ of current rate (to $15\\,\\mathrm{mL/h}$); administer IV sodium phosphate $15\\,\\mathrm{mmol}$ over $6$ hours; continue sliding-scale insulin targeting glucose $<140\\,\\mathrm{mg/dL}$; administer oral magnesium oxide $400\\,\\mathrm{mg}$.\n\nE. Increase EN to $40\\,\\mathrm{mL/h}$ to prevent catabolism; administer IV potassium phosphate $10\\,\\mathrm{mmol}$ over $30$ minutes; no additional vitamin supplementation is needed; recheck electrolytes the next morning.",
            "solution": "### Step 1: Extract Givens\n\n-   **Patient Profile:** $62$-year-old male, postoperative day $3$ after laparoscopic gastrojejunostomy.\n-   **Indication for Surgery:** Gastric outlet obstruction.\n-   **Nutritional History:** Prolonged inadequate oral intake.\n-   **Weight:** Current weight $70\\,\\mathrm{kg}$, down from $79\\,\\mathrm{kg}$ one month prior (a loss of $9\\,\\mathrm{kg}$, or $11.4\\%$ of initial body weight).\n-   **Physical Exam:** No edema.\n-   **Baseline (Pre-EN) Laboratory Values:**\n    -   Serum albumin: $2.6\\,\\mathrm{g/dL}$\n    -   Phosphate: $3.2\\,\\mathrm{mg/dL}$\n    -   Potassium: $3.6\\,\\mathrm{mEq/L}$\n    -   Magnesium: $1.7\\,\\mathrm{mg/dL}$\n    -   Creatinine: $0.9\\,\\mathrm{mg/dL}$\n    -   Glucose: $102\\,\\mathrm{mg/dL}$\n-   **Nutritional Intervention:** Polymeric enteral nutrition (EN) with energy density $1.5\\,\\mathrm{kcal/mL}$ was initiated at a rate of $30\\,\\mathrm{mL/h}$ via a nasojejunal tube $24$ hours ago.\n-   **Current (Post-EN) Laboratory Values (after 24 hours):**\n    -   Phosphate: $1.1\\,\\mathrm{mg/dL}$\n    -   Potassium: $3.2\\,\\mathrm{mEq/L}$\n    -   Magnesium: $1.5\\,\\mathrm{mg/dL}$\n    -   Creatinine: $0.9\\,\\mathrm{mg/dL}$\n    -   Glucose: $188\\,\\mathrm{mg/dL}$ (on correction-scale insulin)\n-   **Current Clinical Status:**\n    -   Vital signs are stable.\n    -   No respiratory distress or chest pain.\n-   **Clinical Concern:** The surgical team is concerned about refeeding physiology.\n-   **Task:** Select the best immediate management plan that specifies both a reduction in EN delivery and phosphate repletion with explicit dosing and route.\n-   **Assumptions:** Normal renal function is asserted.\n\n### Step 2: Validate Using Extracted Givens\n\nThe problem statement describes a classic clinical case of refeeding syndrome in a high-risk patient.\n\n-   **Scientific Grounding:** The problem is firmly based on the well-established pathophysiology of refeeding syndrome. The patient exhibits multiple significant risk factors: prolonged starvation, significant unintentional weight loss (>$10\\%$ in one month), and baseline malnutrition (low albumin, low-normal baseline electrolytes). The reintroduction of nutrition, even at a seemingly modest rate, has precipitated the hallmark biochemical derangements of the syndrome: a rapid, sharp decline in serum phosphate, potassium, and magnesium, coupled with hyperglycemia. This is due to the insulin surge that promotes the cellular uptake of these electrolytes and glucose for ATP synthesis. The provided laboratory values are clinically realistic and consistent with this diagnosis. The management principles referenced in the prompt (insulin-mediated shifts, ATP demand, electrolyte redistribution) are scientifically correct.\n-   **Well-Posedness:** The problem is well-posed, providing a clear clinical context and sufficient quantitative data to identify the pathology and evaluate the proposed interventions. The question asks for the \"best\" plan, implying a comparison against established clinical guidelines for safety and efficacy. A single best answer among the choices is determinable.\n-   **Objectivity:** The problem is stated in objective, clinical terms, free of ambiguity or subjective claims.\n\nThe problem is valid as it represents a standard, albeit critical, clinical scenario that is scientifically sound, well-posed, and objectively presented.\n\n### Step 3: Derivation of the Correct Management Plan\n\nThe patient has severe refeeding syndrome, characterized by severe hypophosphatemia (phosphate $1.1\\,\\mathrm{mg/dL}$), hypokalemia ($3.2\\,\\mathrm{mEq/L}$), and hypomagnesemia ($1.5\\,\\mathrm{mg/dL}$). The principles of management are:\n\n1.  **Reduce Caloric Intake:** The driving force of the syndrome is the carbohydrate load. The current EN rate is $30\\,\\mathrm{mL/h} \\times 1.5\\,\\mathrm{kcal/mL} = 45\\,\\mathrm{kcal/h}$. Over $24$ hours, this is $1080\\,\\mathrm{kcal}$. For a $70\\,\\mathrm{kg}$ patient, this is $1080/70 \\approx 15.4\\,\\mathrm{kcal/kg/day}$. This rate, while not aggressive, was sufficient to cause the syndrome. Standard guidelines (e.g., ASPEN, NICE) recommend starting nutrition at a much lower rate ($\\leq 10\\,\\mathrm{kcal/kg/day}$) in high-risk patients and reducing the rate if refeeding syndrome develops. Therefore, the EN rate must be reduced.\n2.  **Aggressive IV Electrolyte Repletion:** Oral repletion is inadequate for severe, acute deficits, especially in a postoperative patient with potential gut dysmotility.\n    -   **Phosphate:** A serum level of $1.1\\,\\mathrm{mg/dL}$ is severe hypophosphatemia (levels $<1.5\\,\\mathrm{mg/dL}$ are considered severe). This requires intravenous repletion. A typical dose for severe hypophosphatemia is $0.32-0.64\\,\\mathrm{mmol/kg}$. For a $70\\,\\mathrm{kg}$ patient, this is approximately $22-45\\,\\mathrm{mmol}$. The infusion must be slow, typically over $4-6$ hours, to prevent hypotension and calcium-phosphate precipitation.\n    -   **Potassium:** The patient is hypokalemic. Repleting phosphate with potassium phosphate addresses both deficits simultaneously.\n    -   **Magnesium:** The patient is hypomagnesemic. Magnesium is a cofactor for many cellular pumps, and its deficiency impedes the correction of hypokalemia. IV repletion with magnesium sulfate ($1-2\\,\\mathrm{g}$) is necessary.\n3.  **Thiamine Supplementation:** Thiamine is an essential coenzyme in carbohydrate metabolism. Refeeding a thiamine-deficient patient can precipitate acute Wernicke's encephalopathy or high-output cardiac failure. IV thiamine ($100-250\\,\\mathrm{mg}$) must be administered before or with the initiation/continuation of nutrition.\n4.  **Close Monitoring:** Serum electrolytes (phosphate, potassium, magnesium) and glucose must be monitored frequently (e.g., every $4-8$ hours) until stable. The patient should also have cardiac monitoring.\n5.  **Slow Advancement:** Once electrolytes are corrected and stable, EN can be advanced slowly, typically by no more than $20-33\\%$ of goal calories per day.\n\n### Evaluation of Options\n\n**A. Reduce EN delivery to approximately $10\\,\\mathrm{kcal/kg/day}$ by decreasing the EN rate to about $20\\,\\mathrm{mL/h}$ of the $1.5\\,\\mathrm{kcal/mL}$ formula; administer intravenous (IV) potassium phosphate $30\\,\\mathrm{mmol}$ over $4$–$6$ hours; give IV magnesium sulfate $2\\,\\mathrm{g}$; give thiamine $100\\,\\mathrm{mg}$ IV before further advancing feeds; monitor phosphate, potassium, magnesium, and glucose every $6$–$8$ hours and advance EN by $\\leq 20\\%$ per day as electrolytes stabilize.**\n\n-   **EN Reduction:** Rate is reduced to $20\\,\\mathrm{mL/h}$. This provides $20\\,\\mathrm{mL/h} \\times 1.5\\,\\mathrm{kcal/mL} \\times 24\\,\\mathrm{h} = 720\\,\\mathrm{kcal/day}$. For a $70\\,\\mathrm{kg}$ patient, this is $720/70 \\approx 10.3\\,\\mathrm{kcal/kg/day}$. This is a correct and safe reduction.\n-   **Phosphate/Potassium Repletion:** IV potassium phosphate $30\\,\\mathrm{mmol}$ is an appropriate dose for severe hypophosphatemia in a $70\\,\\mathrm{kg}$ patient. The infusion time of $4-6$ hours is safe. This formulation also addresses the hypokalemia.\n-   **Magnesium Repletion:** IV magnesium sulfate $2\\,\\mathrm{g}$ is a standard and appropriate dose.\n-   **Thiamine:** Administration of a $100\\,\\mathrm{mg}$ IV dose is crucial and correctly included.\n-   **Monitoring/Advancement:** The plan for frequent monitoring and slow advancement is the standard of care.\n-   **Verdict:** **Correct**. This option comprehensively and correctly addresses all key aspects of managing severe refeeding syndrome according to established evidence-based guidelines.\n\n**B. Maintain EN at $30\\,\\mathrm{mL/h}$; administer oral neutral phosphate $500\\,\\mathrm{mg}$ (approximately $16\\,\\mathrm{mmol}$ phosphorus) twice daily; recheck electrolytes in $24$ hours without additional changes.**\n\n-   **EN Rate:** Maintaining the current EN rate will worsen the metabolic derangements. This is incorrect and dangerous.\n-   **Phosphate Repletion:** Oral phosphate is inappropriate for severe ($1.1\\,\\mathrm{mg/dL}$) hypophosphatemia due to slow and potentially unreliable absorption. The dose is also likely insufficient.\n-   **Monitoring:** Checking electrolytes in $24$ hours is too infrequent for a patient at risk of life-threatening arrhythmias.\n-   **Omissions:** This plan neglects to replete magnesium or administer thiamine.\n-   **Verdict:** **Incorrect**. This approach is unsafe and constitutes mismanagement.\n\n**C. Stop EN entirely for $72$ hours; administer IV sodium phosphate $60\\,\\mathrm{mmol}$ over $1$ hour; initiate an insulin infusion to target glucose $<110\\,\\mathrm{mg/dL}$; resume EN at goal thereafter.**\n\n-   **EN Management:** Complete cessation for $72$ hours is unnecessarily catabolic. The goal is to reduce, not stop, feeding. Resuming at \"goal\" is too aggressive.\n-   **Phosphate Repletion:** Administering $60\\,\\mathrm{mmol}$ of phosphate over $1$ hour is extremely dangerous and far exceeds safe infusion rates (typically max $\\approx 7\\,\\mathrm{mmol/h}$). This can cause fatal hypotension, acute hypocalcemia, and metastatic calcification. Using sodium phosphate ignores the hypokalemia.\n-   **Glucose Management:** A glucose target of $<110\\,\\mathrm{mg/dL}$ is excessively tight for this patient population and increases hypoglycemia risk.\n-   **Omissions:** No mention of magnesium or thiamine repletion.\n-   **Verdict:** **Incorrect**. This plan is reckless and potentially lethal.\n\n**D. Reduce EN to $50\\%$ of current rate (to $15\\,\\mathrm{mL/h}$); administer IV sodium phosphate $15\\,\\mathrm{mmol}$ over $6$ hours; continue sliding-scale insulin targeting glucose $<140\\,\\mathrm{mg/dL}$; administer oral magnesium oxide $400\\,\\mathrm{mg}$.**\n\n-   **EN Reduction:** Reducing to $15\\,\\mathrm{mL/h}$ ($7.7\\,\\mathrm{kcal/kg/day}$) is a safe reduction.\n-   **Phosphate Repletion:** A dose of $15\\,\\mathrm{mmol}$ is likely insufficient for severe hypophosphatemia. Using sodium phosphate fails to address the concurrent hypokalemia.\n-   **Magnesium Repletion:** Oral magnesium oxide has very poor bioavailability and is not suitable for acute repletion. IV magnesium sulfate is required.\n-   **Omissions:** This plan critically omits thiamine administration.\n-   **Verdict:** **Incorrect**. While the EN reduction is reasonable, the repletion strategy is suboptimal (insufficient phosphate dose, wrong cation) and unsafe (ineffective magnesium repletion, no thiamine).\n\n**E. Increase EN to $40\\,\\mathrm{mL/h}$ to prevent catabolism; administer IV potassium phosphate $10\\,\\mathrm{mmol}$ over $30$ minutes; no additional vitamin supplementation is needed; recheck electrolytes the next morning.**\n\n-   **EN Management:** Increasing the EN rate is the opposite of the correct action and will worsen the refeeding syndrome.\n-   **Phosphate Repletion:** A dose of $10\\,\\mathrm{mmol}$ is insufficient. Infusion over $30$ minutes is dangerously rapid.\n-   **Omissions:** Stating no vitamin supplementation is needed is a grave error; thiamine is mandatory.\n-   **Monitoring:** Rechecking labs the next morning is inadequate.\n-   **Verdict:** **Incorrect**. Every component of this plan is wrong and dangerous.",
            "answer": "$$\\boxed{A}$$"
        }
    ]
}